Alan Taylor

Mr. Alan Taylor is a high-net-worth investor based in Eveleigh, Australia. He has a background as a scientist, investment banker, entrepreneur, and investor. He is currently very active in the Australian start-up area, investing in, advising and taking an active role within a number of early-stage companies. Alan is currently the Chairman and co-founder of Mizzen Group Pty Ltd, a new technology start-up company in the transport and logistics area. Alan is also the Executive Chairman at Clarity Pharmaceuticals, a company focused on developing radiopharmaceuticals for the treatment of cancer and other diseases. Alan is passionate about the commercialization of Australian science and technologies, either in general technology or the life sciences. Alan has approximately 10 years of investment banking experience and was until recently an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank, where he remains on the Board of Directors. Alan has significant experience in capital raisings, mergers and acquisitions, and general corporate advisory. He has experience across a broad range of industries including healthcare and life sciences, technology, and resources. Alan is also a lecturer at the University of Sydney, lecturing to Masters of Commerce and International Business students undertaking studies in New Business Opportunities and Start-ups. Alan completed an undergraduate degree in Applied Science at the University of Sydney, where he finished first in his year and won the prestigious University Medal. He completed his Ph.D. in Medicine at the Garvan Institute of Medical Research, where he investigated the molecular mechanisms of skeletal muscle insulin resistance. Alan has also completed a Graduate Diploma in Applied Finance at the Securities Institute of Australia.